NanoSyrinx
Nick is a Reader at the University of Warwick and co-founded NanoSyrinx with Joe and Alexia whilst supervising them both as members of his academic lab. In his academic role, Nick is particularly interested in the evolution of virulence in emerging human pathogens, and originally discovered the technology at the heart of NanoSyrinx. He retains his academic position at Warwick and advises the company in a non-exec scientific advisory and directorship capacity.
He holds a PhD from Gonville and Caius College, Cambridge in Molecular Bacteriology, and was previously a Lecturer at Bath University.
This person is not in the org chart
This person is not in any offices
NanoSyrinx
NanoSyrinx is a cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector.